A 23-year-old woman with juvenile-onset α-mannosidosis developed an axonal polyneuropathy more than a year following successful unrelated donor (URD) BMT complicated by chronic graft-versus-host ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Explore comprehensive treatments for CIDP, including corticosteroids, plasma exchange, immunoglobulin therapy, and others.

Occupational and Environmental Medicine, Vol. 57, No. 1 (Jan., 2000), pp. 19-27 (9 pages) Background—A patient with unexplained minor behavioural changes associated with an axonal sensorimotor ...

Polyneuropathy is a condition in which a person’s peripheral nerves are damaged. It affects the nerves in your skin, muscles, and organs. When these nerves are damaged, they can’t send regular signals ...

"Alterations in axonal membrane and channel function occur early in the disease course, prior to discernable large fibre involvement, and has the potential to be used as an early biomarker of ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired neurological disorder with heterogeneous presentation. It is a peripheral nerve system immune-mediated condition which ...